Rasagilin NOBEL 1 mg, Tabletten

7680677110023 CH-67711 Tabletten
Rasagilin NOBEL 1 mg, Tabletten
Rasagilin NOBEL 1 mg, Tabletten
Rasagilin NOBEL 1 mg, Tabletten
1 / 3
google

Article details

Package size
100
Selling units
100
Measure
Tablette(n)
Galenic form
Tabletten
Galenic group
Tabletten

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
17/03/2021
Patient information leaflet
Français
17/03/2021
Patient information leaflet
Italien
17/03/2021
Summary of Product Characteristics
Allemand
17/03/2021
Summary of Product Characteristics
Français
17/03/2021
Summary of Product Characteristics
Italien
17/03/2021

Detailed composition

Substance Quantity Type Category
(N/A)
1.0 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance WIZUS
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK

Reimbursement information

Public price
CHF 194.70
Specialties list
Yes
Generic
Yes
SL addition date: 01/04/2021

Authorization holder

NOBEL Pharma Schweiz AG

6343 Risch

Authorization information

Swissmedic authorization number
67711
Drug name
Rasagilin NOBEL, Tabletten
Galenic form
TAB
ATC Code
N04BD02
Authorization status
Z
Dispensing category
B
First authorization
18/05/2020
Authorization expiration date
31/12/9999
IT Number
01.08.0.
Domain
Human medicine
Field of application
Morbus Parkinson

Package details

Description (FR)
RASAGILIN NOBEL cpr 1 mg 100 pce
Description (DE)
RASAGILIN NOBEL Tabl 1 mg 100 Stk
Market launch
18/05/2020
Narcotic (BTM)
No

Original drug

Azilect, Tabletten
GTIN: 7680570650046
CHF 236.75
View original

Other package sizes (1)

RASAGILIN NOBEL cpr 1 mg 30 pce
30 TABL
GTIN: 7680677110016
View